Insider Buying and Selling - XERS

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
03/02/2026 10b5-1	03/04/2026	Hecht Beth Chief Legal Officer and Corporate Secretary Officer	Sell	-16,667 @ $6.25	($104,085.74)	1,226,507	(-1.34%)	Direct
02/02/2026 10b5-1	02/02/2026	Hecht Beth Chief Legal Officer and Corporate Secretary Officer	Sell	-16,667 @ $7.45	($124,147.48)	1,243,174	(-1.32%)	Direct
01/08/2026 10b5-1	01/09/2026	Mcculloch Kevin President and Chief Operating Officer Officer	Sell	-15,000 @ $8.00	($120,000.00)	1,685,426	(-0.88%)	Direct
01/02/2026 10b5-1	01/05/2026	Hecht Beth Chief Legal Officer and Corporate Secretary Officer	Sell	-16,667 @ $7.43	($123,775.81)	1,308,103	(-1.26%)	Direct
12/01/2025 10b5-1	12/02/2025	Hecht Beth Chief Legal Officer and Corporate Secretary Officer	Sell	-16,667 @ $7.01	($116,780.67)	1,320,176	(-1.25%)	Direct
11/11/2025 10b5-1	11/13/2025	Hecht Beth Chief Legal Officer and Corporate Secretary Officer	Sell	-16,667 @ $7.40	($123,295.80)	1,336,843	(-1.23%)	Direct
06/13/2025	06/16/2025	Mcculloch Kevin President and Chief Operating Officer Officer	Buy	25,000 @ $4.38	$109,475.00	1,708,585	(1.48%)	Direct

Xeris Biopharma Holdings, Inc. - XERS